March 1, 2022 | Market Access, oncology
Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies
With CAR-Ts continuing to take centre stage as a paradigm shift in the treatment of cancer, Tania Rodrigues investigates how market access and hospital processes will need to transform to accommodate the influx of these innovative therapies.
Download the white paper here: https://bit.ly/36T8d5j
This content was provided by Inizio
Latest Content from Inizio
Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects
The ideal route of admin isn’t clear cut in the global marketplace
In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these…
Our best practice approach to tracking studies.
The remote exchange of data between patients and their clinician
Our client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and…
Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients…
Published in eyeforpharma October 2016 by Marc Yates
Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in…
In association with PMGroup
